AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Moberg Pharma

Major Shareholding Notification Jan 28, 2019

3174_iss_2019-01-28_21e5e01c-fb6a-4c53-930d-7e26bb7f9f89.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Moberg Pharma AB (publ)

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Buy
Date 25/01/2019
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 1,770,622
Directly held voting rights 0
Indirectly held voting rights 1,770,622
Percentage
Directly held shares 10.001 %
Directly held voting rights 0 %
Indirectly held voting rights 10.001 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 10.001 % 1,770,622
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
0.006 % 1,000
Total 10.007 % 1,771,622

Group total holdings

Voting rights 1,771,622 Percentage of voting rights 10.007

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har förvärvat de aktuella aktierna.

Published

28/01/2019 13:36

Contact

Name Jonas Lexmark Phone 08-40942107 Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.